Coya Therapeutics, Inc. SEC filings COYA
Coya Therapeutics, Inc. has 230 filings in SEC EDGAR's recent list, going back to Jan 5, 2021. Its latest annual report, Form ARS, was filed on May 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2026 | — |
| EFFECT | Filing | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| EFFECT | Filing | Nov 29, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| D | Filing | Oct 28, 2024 | — |
| EFFECT | Filing | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2024 | — |
| EFFECT | Filing | Jan 12, 2024 | — |
| CORRESP | Letter to the SEC | Jan 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2024 | — |
| D | Filing | Dec 20, 2023 | — |
| EFFECT | Filing | May 10, 2023 | — |
| CERT | Filing | Dec 29, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 28, 2022 | — |
| EFFECT | Filing | Dec 28, 2022 | — |
| 8-A12B | Filing | Dec 27, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| CORRESP | Letter to the SEC | Dec 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2022 | — |
| CORRESP | Letter to the SEC | Dec 5, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2022 | — |
| SEC STAFF LETTER | Filing | Nov 23, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| DRSLTR | Filing | Oct 28, 2022 | — |
| DRS/A | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| DRSLTR | Filing | Oct 7, 2022 | — |
| DRS/A | Filing | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| DRS | Filing | Aug 19, 2022 | — |
| D | Filing | May 20, 2022 | — |
| D | Filing | Jan 5, 2021 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835022
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.